Skadden has advised the Evaluation Committee of the Board for Dell Technologies. Dell Technologies has completed a redomestication process, relocating its jurisdiction to the state of...
Dell Technologies Redomesticates to Texas
FTAI Infrastructure to Sell Long Ridge Energy & Power to MARA Holdings for $1.52 Billion
Skadden, Arps, Slate, Meagher & Flom LLP has advised FTAI Infrastructure Inc. Barclays Capital Inc., Compass Point Research & Trading, LLC, Paul, Weiss, Rifkind, Wharton &...
Bitfarms Plans U.S. Redomiciliation and Rebranding to Keel Infrastructure
Skadden, Arps, Slate, Meagher & Flom and Osler, Hoskin & Harcourt have advised Bitfarms Ltd. in connection with its planned redomiciliation from Canada to the United...
XenoTherapeutics to Acquire ESSA Pharma in All-Cash Agreement Backed by XOMA Royalty
Skadden, Arps, Slate, Meagher & Flom LLP, alongside Blake, Cassels & Graydon LLP, have advised ESSA Pharma Inc. Stikeman Elliott LLP and Gibson, Dunn & Crutcher...
Alcon Announces Acquisition of LumiThera and Photobiomodulation Device for Dry AMD
Skadden has advised Alcon. Alcon has announced its intention to acquire LumiThera, Inc., a company recognized for its light-based innovations in ophthalmology, along with its photobiomodulation...
Cycle Pharma’s Acquisition of Banner Life Sciences
Skadden advised Banner Life Sciences, while Goodwin Procter advised Cycle Pharma on the deal. Cycle Pharmaceuticals, Inc. (Cycle) announced the completion of the acquisition of Banner...
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Novartis’ Acquisition of MorphoSys
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
The RMR Group’s Acquisition of CARROLL Multifamily Platform
Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal advisor to RMR, while King & Spalding LLP is acting as legal advisor to CARROLL....
GSK’s Acquisition of BELLUS Health
Paul, Weiss, Rifkind, Wharton & Garrison LLP, and Stikeman Elliott LLP advised GSK, while Skadden, Arps, Slate, Meagher & Flom LLP, and Davies Ward Phillips &...
ABP Acquisition’s $43.8 Million Acquisition of AlerisLife
Skadden advised ABP Acquisition on the deal. AlerisLife Inc. (“ALR”) has entered into a definitive agreement with ABP Acquisition LLC under which ABP will acquire all...